Advisor Group Holdings, Inc. Supernus Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,129 shares of SUPN stock, worth $40,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,129
Previous 1,087 3.86%
Holding current value
$40,779
Previous $29,000 20.69%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$25.77 - $35.16 $1,082 - $1,476
42 Added 3.86%
1,129 $35,000
Q2 2024

Aug 13, 2024
SELL
$25.99 - $33.85 $56,866 - $74,063
-2,188 Reduced 66.81%
1,087 $29,000
Q1 2024

May 10, 2024
SELL
$27.11 - $35.17 $171,741 - $222,801
-6,335 Reduced 65.92%
3,275 $111,000
Q4 2023

Feb 12, 2024
SELL
$22.72 - $29.68 $72,885 - $95,213
-3,208 Reduced 25.03%
9,610 $278,000
Q3 2023

Nov 13, 2023
BUY
$27.57 - $32.91 $123,954 - $147,963
4,496 Added 54.03%
12,818 $353,000
Q2 2023

Aug 10, 2023
BUY
$29.91 - $38.73 $2,123 - $2,749
71 Added 0.86%
8,322 $250,000
Q1 2023

May 12, 2023
SELL
$34.93 - $42.03 $3,283 - $3,950
-94 Reduced 1.13%
8,251 $298,000
Q4 2022

Feb 10, 2023
SELL
$31.09 - $37.88 $481,739 - $586,950
-15,495 Reduced 65.0%
8,345 $297,000
Q3 2022

Nov 14, 2022
BUY
$28.79 - $35.41 $558,900 - $687,414
19,413 Added 438.51%
23,840 $806,000
Q2 2022

Aug 10, 2022
BUY
$25.33 - $34.25 $4,280 - $5,788
169 Added 3.97%
4,427 $127,000
Q1 2022

May 04, 2022
BUY
$28.51 - $32.9 $6,813 - $7,863
239 Added 5.95%
4,258 $138,000
Q3 2021

Nov 05, 2021
SELL
$23.54 - $31.39 $3,413 - $4,551
-145 Reduced 3.48%
4,019 $107,000
Q2 2021

Aug 02, 2021
BUY
$26.72 - $33.19 $4,515 - $5,609
169 Added 4.23%
4,164 $129,000
Q1 2021

May 13, 2021
BUY
$24.15 - $31.45 $60,713 - $79,065
2,514 Added 169.75%
3,995 $104,000
Q4 2020

Feb 10, 2021
SELL
$17.7 - $25.81 $47,436 - $69,170
-2,680 Reduced 64.41%
1,481 $38,000
Q3 2020

Nov 12, 2020
BUY
$20.2 - $25.05 $2,504 - $3,106
124 Added 3.07%
4,161 $87,000
Q2 2020

Aug 14, 2020
BUY
$17.09 - $24.89 $9,040 - $13,166
529 Added 15.08%
4,037 $95,000
Q1 2020

May 18, 2020
BUY
$14.45 - $24.69 $50,690 - $86,612
3,508 New
3,508 $63,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.93B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email